Adverum Biotechnologies, Inc. (ADVM) Net Income by Year
Adverum Biotechnologies, Inc. reported a net loss of $130.9M in fiscal year 2024. This represents a decrease of 7.2% from the prior fiscal year. The table below carries 13 fiscal years, from 2012 to 2024, and the quarters Adverum Biotechnologies, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADVM Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ADVM Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Adverum Biotechnologies, Inc. financials
Frequently Asked Questions
What was Adverum Biotechnologies, Inc.'s net income in fiscal year 2024?
Adverum Biotechnologies, Inc. reported a net loss of $130.9M in fiscal year 2024.
How fast is Adverum Biotechnologies, Inc.'s net income growing?
Adverum Biotechnologies, Inc. (ADVM) net income fell by 7.2% year over year, from -$122.1M to -$130.9M in fiscal year 2024.
How has Adverum Biotechnologies, Inc.'s net income changed over the years?
Across the 13 fiscal years this page covers, Adverum Biotechnologies, Inc. (ADVM) net income went from -$1.8M in fiscal year 2012 to -$130.9M in fiscal year 2024.
What was Adverum Biotechnologies, Inc.'s net income in the most recent quarter?
Adverum Biotechnologies, Inc. (ADVM) reported -$47.7M in net income in Q3 2025. This represents a decrease of 47.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Adverum Biotechnologies, Inc. (ADVM) reported on that line in every period on record.